Abstract
Simultaneously, we realised a randomized trial neo-adjuvant chemotherapy concerning tumors T3T4 and compared two groups of tumors T2 (study non randomized) one receiving a neo-adjuvant chemotherapy in association with (CDDP, 100 mg/m2 and 5-FU, 1,000 mg/day, continuously during 5 days); the other receiving surgical treatement from the start.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag France
About this paper
Cite this paper
Lacoste, J.P., Szpirglas, H., Nizri, D., Thomas, A., Godeau, S., Benslama, L. (1991). Neo-Adjuvant chemotherapy on T2 cancers in oropharyngeal and oral-cavity. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy. Springer, Paris. https://doi.org/10.1007/978-2-8178-0782-9_21
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0782-9_21
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0784-3
Online ISBN: 978-2-8178-0782-9
eBook Packages: Springer Book Archive